Update shared on 12 Dec 2025
Fair value Increased 12%Analysts have raised their price target on RLX Technology from approximately 2.34 dollars to 2.61 dollars, citing expectations for stronger profit margins that more than offset slightly slower projected revenue growth and a marginally higher discount rate.
Valuation Changes
- Fair Value: increased moderately from 2.34 dollars to 2.61 dollars per share, reflecting higher estimated intrinsic value.
- Discount Rate: risen slightly from 7.80 percent to approximately 7.98 percent, implying a marginally higher required return.
- Revenue Growth: reduced modestly from about 19.26 percent to roughly 17.36 percent, indicating slightly more conservative top line expectations.
- Net Profit Margin: improved moderately from around 17.05 percent to about 18.64 percent, signaling expectations for stronger profitability.
- Future P/E: declined slightly from roughly 30.0 times to about 28.4 times forward earnings, suggesting a marginally lower valuation multiple applied to future profits.
Have other thoughts on RLX Technology?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystLowTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystLowTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystLowTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.